超聲聯(lián)合鉬靶、MRI檢查對早期乳腺癌診斷的價值分析

張永亭

[摘要] 目的 探討超聲聯(lián)合鉬靶、MRI檢查對早期乳腺癌診斷的價值。 方法 隨機選取2015年1月～2018年7月在我院行早期乳腺癌治療的患者共50例，所有患者均行超聲聯(lián)合鉬靶、MRI檢查，對比分析3種檢查方法的特異性、敏感性、準確性。 結果 超聲聯(lián)合鉬靶、MRI診斷惡性42例，良性8例;超聲診斷惡性31例，良性19例;鉬靶診斷惡性25例，良性25例;MRI診斷惡性43例，良性7例。MRI檢查方式的特異性、敏感性、準確性分別為66.00%、64.00%、74.00%;鉬靶檢查方式的特異性、敏感性、準確性分別為70.00%、62.00%、66.00%;超聲檢查方式的特異性、敏感性、準確性分別為50.00%、56.00%、40.00%;超聲聯(lián)合鉬靶、MRI檢查方式的特異性、敏感性、準確性分別為80.00%、82.00%、78.00%，超聲聯(lián)合鉬靶、MRI檢查方式的特異性、敏感性、準確性均高于MRI、鉬靶、超聲檢查方式，組間差異有統(tǒng)計學意義（P<0.05）。 結論 給予早期乳腺癌患者采用超聲聯(lián)合鉬靶、MRI檢查利于提升診斷準確率，為臨床治療人員提供強有力的診斷依據(jù)，值得臨床廣泛推廣應用。

[關鍵詞] 超聲;鉬靶;MRI;早期乳腺癌;醫(yī)學影像

[中圖分類號] R737.9;R445;R730.44? ? ? ? ?[文獻標識碼] B? ? ? ? ?[文章編號] 1673-9701（2019）17-0108-04

[Abstract] Objective To explore the value of ultrasound combined with molybdenum target and MRI in the diagnosis of early breast cancer. Methods A total of 50 patients who underwent early breast cancer treatment in our hospital from January 2015 to July 2018 were randomly selected. All patients were treated with ultrasound combined with molybdenum target and MRI. The specificity， sensitivity and accuracy of the three methods were compared and analyzed. Results Of the results of ultrasound combined with molybdenum target and MRI， 42 cases were malignant and 8 cases were benign; The results of ultrasound diagnosis were malignant in 31 cases and benign in 19 cases; results of molybdenum target diagnosis were malignant in 25 cases and benign in 25 cases; and MRI diagnosis showed malignancy in 43 cases and benign in 7 cases. The specificity， sensitivity and accuracy of MRI were 66.00%， 64.00%， and 74.00%， respectively. The specificity， sensitivity， and accuracy of molybdenum target were 70.00%， 62.00%， and 66.00%， respectively. The specificity， sensitivity and accuracy of the ultrasound examination were 50.00%， 56.00%， and 40.00%， respectively. The specificity， sensitivity， and accuracy of ultrasound combined with molybdenum target and MRI were 80.00%， 82.00%， and 78.00%， respectively. The specificity， sensitivity and accuracy of ultrasound combined with molybdenum target and MRI were higher than those of MRI， molybdenum target or ultrasonography. The differences were statistically significant（P<0.05）. Conclusion In patients with early breast cancer， the use of ultrasound combined with molybdenum target and MRI can improve the diagnostic accuracy and provide a strong diagnostic basis for clinical staff， which is worthy of widespread clinical application.

[Key words] Ultrasound; Molybdenum target; MRI; Early breast cancer; Medical imaging